HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sheng-Tung Huang Selected Research
Sheng-Tung Huang Research Topics
Disease
5
Neoplasms (Cancer)
01/2024 - 06/2004
5
Inflammation (Inflammations)
04/2017 - 05/2005
2
Cardiovascular Diseases (Cardiovascular Disease)
07/2023 - 01/2013
1
COVID-19
08/2023
1
Virus Diseases (Viral Diseases)
08/2023
1
Infections
12/2022
1
Neoplasm Metastasis (Metastasis)
05/2022
1
Chronic Renal Insufficiency
01/2021
1
Smear Layer
11/2019
1
Glioma (Gliomas)
06/2011
1
Carcinogenesis
05/2005
Drug/Important Bio-Agent (IBA)
5
Biomarkers (Surrogate Marker)
IBA
01/2024 - 02/2020
1
gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)
IBA
01/2024
1
Glucose (Dextrose)
FDA Link
Generic
08/2023
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
08/2023
1
Hydrogen Peroxide (Hydroperoxide)
FDA Link
Generic
08/2023
1
Blood Glucose (Blood Sugar)
IBA
08/2023
1
RNA (Ribonucleic Acid)
IBA
12/2022
1
Ubiquinone
IBA
12/2022
1
Carbohydrates
IBA
12/2022
1
Vitamin K 2 (Vitamin K2)
IBA
12/2022
1
CD13 Antigens (Alanine Aminopeptidase)
IBA
05/2022
1
Formaldehyde (Formol)
FDA Link
01/2021
1
Creatinine
IBA
01/2021
1
Leucyl Aminopeptidase (Peptidase S)
IBA
02/2020
1
Peptide Hydrolases (Proteases)
FDA Link
02/2020
1
Metals
IBA
11/2019
1
Solutions
IBA
11/2019
1
Ions
IBA
11/2019
1
Acids
IBA
11/2019
1
Nitric Oxide Synthase (NO Synthase)
IBA
04/2017
1
ovalbumin-alum
IBA
04/2017
1
Lipopolysaccharides
IBA
04/2017
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
04/2017
1
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
IBA
04/2017
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
04/2017
1
bromorutaecarpine
IBA
01/2013
1
rutecarpine
IBA
01/2013
1
Mitogen-Activated Protein Kinases
IBA
06/2011
1
caffeic acid phenethyl ester
IBA
06/2011
1
Thalidomide (Thalomid)
FDA Link
09/2008
1
Xanthine
IBA
01/2008
1
isovitexin
IBA
05/2005
1
bis-aziridinylnaphthoquinone
IBA
06/2004
1
Proteins (Proteins, Gene)
FDA Link
06/2004
Therapy/Procedure
2
Therapeutics
01/2013 - 06/2011